SUSQUEHANNA INTERNATIONAL GROUP, LLP - ALPINE IMMUNE SCIENCES INC ownership

ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 77 filers reported holding ALPINE IMMUNE SCIENCES INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of ALPINE IMMUNE SCIENCES INC
ValueSharesWeighting
Q2 2023$117,716
+43.4%
11,451
+7.7%
0.00%
Q1 2023$82,094
-49.6%
10,634
-52.0%
0.00%
Q4 2022$162,891
+35.7%
22,162
+56.9%
0.00%
Q2 2022$120,000
+8.1%
14,121
+13.7%
0.00%
Q1 2022$111,000
-82.5%
12,421
-79.2%
0.00%
Q1 2021$633,00059,7280.00%
Other shareholders
ALPINE IMMUNE SCIENCES INC shareholders Q2 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,571,450$17,640,0004.25%
BVF INC/IL 1,201,717$8,244,0000.92%
Orbimed Advisors 3,670,955$25,183,0000.39%
TIGER MANAGEMENT L.L.C. 137,728$945,0000.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 475,450$3,262,0000.12%
Hikari Power Ltd 122,972$844,0000.09%
ALPINE WOODS CAPITAL INVESTORS, LLC 15,000$103,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 35,750$245,0000.00%
DRW Securities, LLC 10,000$69,0000.00%
VICTORY CAPITAL MANAGEMENT INC 134,542$923,0000.00%
View complete list of ALPINE IMMUNE SCIENCES INC shareholders